Creation of Medications
Over the years, the development of drugs has significantly increased with a proper understanding of the mode and mechanism of action, indications, side effects as well as issues of overdose. Although the process of coming up with a drug is long, it ensures that an effective medication with the least side effects and safe is discovered and has undergone necessary tests. This paper will describe a medication, including its side effects and dosage to different individuals and the process that the drug undergoes before it is approved for marketing.
Tandarin is an anticoagulant medication (named because of the therapeutic effect) that works in reducing blood clotting and thus reduces complications that could have resulted from them. The drug will be given a chemical name based on its atomic molecular structure, tandarin is its generic name given by the United States Adopted Names (USAN) Council, and Glendin as its brand name assigned by the company for the purpose of marketing. It is available in both tablets and intravenous solution.
The methods that can be used to administer the drug include the oral and intravenous (IV) route. The former involves taking drug tablets through the mouth with water while IV involves injecting the drug directly to a vein. The drug through the oral route is absorbed in the small intestine and then moved to the liver before it goes back to the bloodstream to the target organ. One of the side effects of the medication is bleeding, which can be severe in the case of overdose.
The dilution of the medication is done using sterilized water for injection, as per the recommendations. The dose will be given by the weight in Kgs* Dosage, and it changes because the action of the drug varies in its extension with the body weight. The drug before its approval underwent preclinical phase where it was tested on animals, phase one of a clinical trial involving the determination of safety in humans, phase two of a clinical trial where the drug was given to patients with the disease for efficacy, phase three for testing a larger group and determining the dosage and other factors and finally drug application after collection and analysis of all data. Conclusively, drug creation is a process that involves several steps to promote the development of an effective drug.